Home/Filings/4/0001225208-24-005970
4//SEC Filing

Morano Susan E 4

Accession 0001225208-24-005970

CIK 0000885725other

Filed

May 12, 8:00 PM ET

Accepted

May 13, 4:37 PM ET

Size

11.9 KB

Accession

0001225208-24-005970

Insider Transaction Report

Form 4
Period: 2024-05-09
Transactions
  • Award

    Common Stock

    2024-05-09+4213,953 total
  • Award

    Deferred Stock Units

    2024-05-09+1,4503,532 total
    Common Stock (1,450 underlying)
  • Award

    Deferred Stock Units

    2024-05-09+4213,953 total
    Common Stock (421 underlying)
  • Award

    Common Stock

    2024-05-09+1,4503,532 total
Footnotes (5)
  • [F1]Annual equity award in the form of restricted stock vesting in full upon the next annual meeting of stockholders. Reflects a value of $107,500 (representing 50% of the amount of the non-employee director compensation program's annual equity award having a value of $215,000) divided by the closing price of common stock on the date of grant.
  • [F2]Grant of restricted stock in lieu of 25% yearly cash compensation. Reflects a value of approximately $31,250 (representing 25% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant.
  • [F3]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  • [F4]Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Director service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $107,500 (representing 50% of the non-employee director compensation program's annual equity award having a value of $215,000) divided by the closing price of common stock on the date of grant.
  • [F5]Deferred stock units were granted in lieu of 25% yearly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Reflects a value of $31,250 (representing 25% of the amount of the non-employee director compensation program's cash retainer having a value of $125,000) divided by the closing price of the common stock on the date of grant.

Documents

1 file

Issuer

BOSTON SCIENTIFIC CORP

CIK 0000885725

Entity typeother

Related Parties

1
  • filerCIK 0001983791

Filing Metadata

Form type
4
Filed
May 12, 8:00 PM ET
Accepted
May 13, 4:37 PM ET
Size
11.9 KB